Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Status: | Recruiting |
---|---|
Conditions: | Colorectal Cancer, Liver Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Cancer, Endocrine, Gastrointestinal, Gastrointestinal, Gastrointestinal, Gastrointestinal, Gastrointestinal, Gastrointestinal, Gastrointestinal, Gastrointestinal, Pancreatic Cancer |
Therapuetic Areas: | Endocrinology, Gastroenterology, Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | July 2011 |
End Date: | September 2017 |
Contact: | Michel Kahaleh, MD |
Email: | mik9071@med.cornell.edu |
Phone: | 646-962-4000 |
Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ),
Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year.
Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or
plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients
suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal
disorders. The investigators would like to assess prospectively the efficacy and safety of
these routine procedures to permit identification of technical details about the procedures
or other factors which might be associated with outcome or results. Assessment of these
details would help us with problem identification and recommendations to improve health
outcomes and quality of life in these patients.
Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year.
Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or
plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients
suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal
disorders. The investigators would like to assess prospectively the efficacy and safety of
these routine procedures to permit identification of technical details about the procedures
or other factors which might be associated with outcome or results. Assessment of these
details would help us with problem identification and recommendations to improve health
outcomes and quality of life in these patients.
Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ),
Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year.
Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or
plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients
suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal
disorders. The investigators would like to assess prospectively the efficacy and safety of
these routine procedures to permit identification of technical details about the procedures
or other factors which might be associated with outcome or results. Assessment of these
details would help us with problem identification and recommendations to improve health
outcomes and quality of life in these patients.
Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year.
Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or
plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients
suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal
disorders. The investigators would like to assess prospectively the efficacy and safety of
these routine procedures to permit identification of technical details about the procedures
or other factors which might be associated with outcome or results. Assessment of these
details would help us with problem identification and recommendations to improve health
outcomes and quality of life in these patients.
Inclusion Criteria:
- Any subject that underwent Interventional Endoscopy for Pancreatico-biliary,
Gastrointestinal or Esophageal disorders.
- Above the age of 18 years
Exclusion Criteria:
- Any group that did not undergo Interventional Endoscopy for Pancreatico-biliary,
Gastrointestinal or Esophageal disorders.
- Below the age of 18 years
We found this trial at
1
site
Click here to add this to my saved trials